Cargando…
Wnt/β-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells
BACKGROUND: Trastuzumab is the only approved target agent for the first-line treatment of human epidermal growth factor receptor-2 (HER-2) positive gastric cancer; however, trastuzumab resistance is a major problem in clinical practice. To comprehend the mechanism of trastuzumab resistance, we focus...
Autores principales: | Kim, Yuna, Bae, Yoo Jin, Kim, Jie-Hyun, Kim, Hyunki, Shin, Su-Jin, Jung, Da Hyun, Park, Hyojin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542239/ https://www.ncbi.nlm.nih.gov/pubmed/37773114 http://dx.doi.org/10.1186/s12885-023-11447-4 |
Ejemplares similares
-
Metabolome-Wide Reprogramming Modulated by Wnt/β-Catenin Signaling Pathway
por: Park, Soo Jin, et al.
Publicado: (2023) -
Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway
por: Vallée, Alexandre
Publicado: (2022) -
Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways
por: Kang, Jung-Il, et al.
Publicado: (2017) -
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer
por: Kang, Hyeon Woong, et al.
Publicado: (2023) -
Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy
por: Bisson, Sarah-Kim, et al.
Publicado: (2018)